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Abstract. To facilitate the separation of 89Zr produced in yttrium foils, an automated separation 
module was designed and assembled. The module separates more than 85% of produced 89Zr –
activity in 3 g foils in less than 90 min. About 10 % remains in the dissolving vial. The quality 
of the separated 89Zr activity was investigated for labeling of the HER2-binding monoclonal 
antibody fragment, trastuzumab-Fab.  
Keywords: 89Zr, PET, Separation Module, Automation.  
PACS: 28.60.+s, 87.57.uk,  87.57.un 
INTRODUCTION 
89Zr (+=22.7 %, t1/2=3.27 d) is a useful radiometal for immuno-PET, the in vivo 
imaging and quantification of monoclonal antibodies (mAbs) with positron emission 
tomography (PET). This is because 89Zr has relatively high + intensity and a physical 
half-life suitably matched to the pharmacokinetics of mAbs in vivo (days). Since the 
first utilization of 89Zr for labeling of intact antibodies was presented,1  89Zr has been 
given a great deal of attention.2 
89Zr is accessible with hospital cyclotrons through the 89Y(p,n)89Zr reaction on 
natural yttrium (89Y =100 %). One common procedure to separate 89Zr from irradiated 
yttrium material is to use a solid-phase hydroxamate resin3,4 from which 89Zr is eluted 
with oxalic acid as [89Zr]Zr-oxalate. In 2010 Vosjan et al.5 published a protocol 
describing the step by step procedure, where separated [89Zr]Zr-oxalate is directly 
used to label mAbs or other proteins pre-conjugated with the commercially available 
bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine (Df-Bz-NCS).  
This work focuses on the separation of 89Zr activity from natural yttrium target 
material with a hydroxamate resin. For this purpose, an automated module was 
designed and assembled. An automated separation module is one important parameter 
in the streamlining of regular 89Zr-production. Additionally, personnel doses are 
decreased with an automated module. 14th International Workshop on Targetry and Target ChemistryAIP Conf. Proc. 1509, 206-210 (2012); doi: 10.1063/1.4773969©   2012 American Institute of Physics 978-0-7354-1127-2/$0.00206
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MATERIAL AND METHODS 
Equipment & Materials 
The module consists of a peristaltic pump (Welco, 6-12 VDC) and 6 dual pinch 
valves (Takasago, 12 VDC) syringes and hydroxamate resin, which are mounted on an 
aluminum plate (Figure 1). On the upper side of the pinch valves, the syringes and the 
hydroxamate resin are connected with Luer Lock tips to a Pharmed BPT tube (1 mm 
i.d and 3 mm o.d). On the lower side of the pinch valves the tubes are connected to a 
common line with 3 way stopcocks (only used as tee-unions).  
Pinch valves and pump are connected via an on/off 8 channel USB relay card 
(Quancom-USBREL8/LC) to 6-12 VDC lines. A PC lap-top with a LabVIEW 
(National Instruments) program is used to control the relay card. The separation 
program starts a sequence which consists of several steps. Each step has a user 
specified valve/pump setting and duration (Figure 2). 
To decrease metal contamination low metal level HCl (Merck 30 % Ultrapur®) and 
water (Sigma Aldrich, Traceselect®) is used. MeCN is pretreated with chelex 100 
resin (Bio-Rad Laboratories) to remove metal ions. 
 
 
FIGURE 1. (a). The module loaded with resin, liquids and an irradiated foil in the dissolving vial.        




FIGURE 2. LabVIEW Valve/Pump control-program 
 207
 Reuse of AIP Publishing content is subject to the terms at: https://publishing.aip.org/authors/rights-and-permissions IP:  130.226.195.3 On: Fri, 30 Sep 2016 07:28:53
Irradiation 
 89Zr is normally produced in ~50x20x0.64 mm, ~3g, yttrium foils (Alfa Aesar 
99.9%) with 45 A, ~12.8 MeV protons with a home-made solid multi-purpose target 
system.6 One hour irradiation results in 2150 ± 197 MBq (n =13).  
Separation 
The automated separation in this work is performed based on the separation 
described by Holland et al.7 Briefly, a home manufactured 100 mg hydroxamate resin 
is manually activated, with MeCN, water, 2 M HCl and connected to the module. Also 
water and HCl-syringes are connected to the module before an irradiated yttrium foil 
is placed in the dissolving vial. The peristaltic pump is placed so that liquids on the 
right side of the pump can go to vials on the left side of the pump and vice versa by 
reversing the direction of the pump rotation i.e. switch the polarity of the motor.  The 
program is started where 6 M HCl is added to dissolve the foil. Because of 
approximately ten times larger target masses in this work compared to Holland et al.,7 
water and HCl volumes are increased proportionally. Due to the violent reaction with 
HCl, foils are dissolved in several steps by pumping 1 ml HCl to the dissolving vial 
and waiting 75 sec before next addition (total of ~18 ml). To collect fumes the exhaust 
is operating during the entire dissolving step by circulating water through a water jet 
vacuum pump. In the next step, water is added to ensure a <2 M HCl concentration. 
The solution is transferred to the resin where 89Zr is trapped. The resin is then washed 
with 2 M HCl and water to remove Y(III) ions and other impurities. The final step is 
to elute 89Zr with 1 M oxalic acid.  
An elution distribution profile was determined with 10 x 200 l 1 M oxalic acid 
injections into the module with a pump speed of ~ 3.5 ml/min (Figure 3). To see any 
difference in separation trends for a smaller foil, the same procedure was also 
performed for irradiated 1.5 g foils. Elution with oxalic acid can be performed using 
either with a prefilled syringe connected to the module or via an external line out from 
the hot cell to the lab as in Figure 1. The latter gives the operator more flexibility if 
several [89Zr]Zr-oxalate batches are to be delivered. 
Labeling 
The separated activity from the third 200 l fraction elute was used to label 
trastuzumab-Fab and tested against HER2 expressing SKOV-3 cells according to 
Siikanen et al.8 The trastuzumab-Fab is obtained by fragmentation using a FragIT kit 
(Genovis, Lund).  
Specific activity 
To calculate specific activity, the amount of cold zirconium was measured with 
inductively coupled plasma optical emission spectrometry (ICP-EOS) with a detection 
limit of 0.5 ppb for zirconium. For the ICP-EOS analysis the first 1 ml eluted oxalic 
acid separated from one un-irradiated foil was analysed.  208
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RESULTS 
Separation of ten 200 l [89Zr]Zr-oxalate fractions took less than 90 min. More than 
85% of the activity measured in foils was collected in total of 2 ml oxalic acid. No 
remarkable differences in elution profiles were observed for a 1.5g and a 3g foil 
separation. Approximately 90% of the activity transferred to the resin was eluted in 
the first milliliter of oxalic acid (Figure 3). 
The overall labeling yield of 89Zr-Df-trastuzumab-Fab was over 99%. The 
radioconjugate was stable in PBS for at least 2 weeks and retained its binding 
specificity to HER2 receptors in vitro (Figure 4).  




FIGURE 3. Elution profile averaged over three separations 
 
FIGURE 4. Binding specificity of 89Zr-trastuzumab-Fab on HER2-expressing SKOV-3 cells. 89Zr-
trastuzumab-Fab binds specifically to HER2 receptors in SKOV-3 cells as shown by a pre-saturation of 
excess of cold trastuzumab (blocked) before addition of labeled substance 209
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DISCUSSION AND CONCLUSIONS 
In this work a relatively large foil has been used, about 5-10 times more yttrium 
than common at other radiopharmaceutical production sites. Approximately 10 % of 
foil activity was trapped in the dissolving vial. This loss is expected to be lower for 
sites with smaller target masses which mean smaller dissolving volumes.  
One hour irradiation yields about 2.1 GBq 89Zr in a 3g foil.  Approximately 1.8 
GBq (85%) of foil activity is eluted in 2 ml oxalic acid.  About 1.6 GBq (90%) of total 
eluted activity is eluted in the first 1 ml oxalic acid fraction according to several 
separations like the example in Figure 3. Provided that irradiation conditions do not 
increase the amount of cold zirconium the specific activity of 89Zr is expected to be 
about 1.5 GBq/g of zirconium (1 h irradiation). However more extensive studies 
involving specific activity and metal contamination measurements have been initiated 
to examine the separated product more thoroughly.  
We have designed a simple and inexpensive automated separation module which 
also reduces personnel doses. This is helpful for sites which aim to distribute large 
amounts of 89Zr activity. The system is flexible and can be useful for other similar 
tasks if the setup and relay-pump sequences are reconfigured. Relay card, pump and 
pinch valves cost about 100 € each. All syringes, 3-way stopcocks and tubes in contact 
with liquids and foil are disposables. 
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